These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32152823)

  • 1. Optimal Radiotherapy Dose in Anal Cancer: Trends in Prescription Dose and Association with Survival.
    Shah NK; Qureshi MM; Dyer MA; Truong MT; Mak KS
    J Gastrointest Cancer; 2021 Mar; 52(1):229-236. PubMed ID: 32152823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Definitive Pelvic Radiotherapy and Survival of Patients With Newly Diagnosed Metastatic Anal Cancer.
    Wang Y; Yu X; Zhao N; Wang J; Lin C; Izaguirre EW; Farmer M; Tian G; Somer B; Dubal N; Schwartz DL; Ballo MT; VanderWalde NA
    J Natl Compr Canc Netw; 2019 Jan; 17(1):29-37. PubMed ID: 30659127
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of dose escalation for large squamous cell carcinomas of the anal canal.
    Prasad RN; Elson J; Kharofa J
    Clin Transl Oncol; 2018 Oct; 20(10):1314-1320. PubMed ID: 29623585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus, radiation dose and survival of patients with anal cancer.
    Kabarriti R; Brodin NP; Ohri N; Narang R; Huang R; Chuy JW; Rajdev LN; Kalnicki S; Guha C; Garg MK
    Acta Oncol; 2019 Dec; 58(12):1745-1751. PubMed ID: 31282249
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in Radiation Dose and Technique For Anal Canal Squamous Cell Carcinoma.
    Wegner RE; Abel S; Hasan S; White RJ; Raj M; Monga D; Finley G; McCormick J; Kirichenko AV
    Am J Clin Oncol; 2019 Jun; 42(6):519-526. PubMed ID: 31136369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal.
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Huart J; Pène F; Schlienger M
    Int J Radiat Oncol Biol Phys; 2003 Aug; 56(5):1259-73. PubMed ID: 12873670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapy.
    Koshy M; Malik R; Sher DJ; Spiotto M; Mahmood U; Aydogan B; Weichselbaum RR
    Clin Lung Cancer; 2014 Sep; 15(5):365-71. PubMed ID: 24984565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anal canal carcinoma: early-stage tumors < or =10 mm (T1 or Tis): therapeutic options and original pattern of local failure after radiotherapy.
    Ortholan C; Ramaioli A; Peiffert D; Lusinchi A; Romestaing P; Chauveinc L; Touboul E; Peignaux K; Bruna A; de La Roche G; Lagrange JL; Alzieu C; Gerard JP
    Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):479-85. PubMed ID: 15890590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiation therapy with simultaneous integrated boost combined with concurrent chemotherapy for the treatment of anal cancer patients: 4-year results of a consecutive case series.
    Franco P; Mistrangelo M; Arcadipane F; Munoz F; Sciacero P; Spadi R; Migliaccio F; Angelini V; Bombaci S; Rondi N; Numico G; Ragona R; Cassoni P; Morino M; Racca P; Ricardi U
    Cancer Invest; 2015 Jul; 33(6):259-66. PubMed ID: 25950188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Survival of Patients With Anal Adenocarcinoma, Squamous Cell Carcinoma of the Anus, and Rectal Adenocarcinoma.
    Franklin RA; Giri S; Valasareddy P; Lands LT; Martin MG
    Clin Colorectal Cancer; 2016 Mar; 15(1):47-53. PubMed ID: 26362848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved survival with dose-escalated radiotherapy in stage III non-small-cell lung cancer: analysis of the National Cancer Database.
    Brower JV; Amini A; Chen S; Hullett CR; Kimple RJ; Wojcieszynski AP; Bassetti M; Witek ME; Yu M; Harari PM; Baschnagel AM
    Ann Oncol; 2016 Oct; 27(10):1887-94. PubMed ID: 27502703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary surgery with or without postoperative radiotherapy in early stage squamous cell carcinoma in the anal canal and anal margin.
    Leon O; Hagberg O; Johnsson A
    Acta Oncol; 2018 Sep; 57(9):1209-1215. PubMed ID: 29490558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of aggressive thoracic radiation therapy and concurrent chemoradiation therapy in metastatic lung cancer.
    Koshy M; Malik R; Mahmood U; Rusthoven CG; Sher DJ
    Pract Radiat Oncol; 2015; 5(6):374-82. PubMed ID: 26412340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Hannoun L; Houry S; Huguet F; Pène F; Parc R; Schlienger M
    Cancer Radiother; 2006 Dec; 10(8):572-82. PubMed ID: 17110148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-tailored Anal Canal Radiotherapy (HIT-ART): Outcomes of a 10-Year Single Center Clinical Experience.
    Manfrida S; Fionda B; Mariani S; Luca V; Bertolini R; Barbaro B; Chiloiro G; Frascino V; Tagliaferri L; Gambacorta MA
    In Vivo; 2024; 38(3):1306-1315. PubMed ID: 38688632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced radiation dose for elective nodal irradiation in node-negative anal cancer: back to the roots?
    Henkenberens C; Meinecke D; Michael S; Bremer M; Christiansen H
    Strahlenther Onkol; 2015 Nov; 191(11):845-54. PubMed ID: 26307627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-dose-rate interstitial brachytherapy boost for the treatment of anal canal cancers.
    Cordoba A; Escande A; Leroy T; Mirabel X; Coche-Dequéant B; Lartigau E
    Brachytherapy; 2017; 16(1):230-235. PubMed ID: 27600606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of brachytherapy in the boost management of anal carcinoma with node involvement (CORS-03 study).
    Moureau-Zabotto L; Ortholan C; Hannoun-Levi JM; Teissier E; Cowen D; Salem N; Lemanski C; Ellis S; Resbeut M
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e135-42. PubMed ID: 23195780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].
    Deniaud-Alexandre E; Touboul E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Huang R; Qu SH; Pène F; Schlienger M
    Cancer Radiother; 2003 Aug; 7(4):237-53. PubMed ID: 12914857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.